FDA Person
Office of Regulatory AffairsCody D. Rickman
View detailed information about Cody D. Rickman, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Cody D. Rickman, including their role, qualifications, and regulatory activities.
Recent Records (31)
Page 1 of 2483 - American CryoStem Corporation
483
EIR - Hospira, Inc., A Pfizer Company
EIR
483 - Emergent Manufacturing Operations Baltimore LLC.
483
483_RESPONSE - Emergent Manufacturing Operations Baltimore LLC.
483_RESPONSE
483 - Western Kentucky Regional Blood Ctr
483
EIR - Cardinal Health dba Specialty Pharmaceutical Services
EIR
483 - Lifesouth Community Blood Centers Inc. - East Alabama Region
483
483 - Celularity Inc
483
483 - Immucor, Inc.
483
483 - Computer Programs & Systems Inc
483
483 - Roche Diagnostics GmbH
483
483 - Department of the Army Blanchfield Army Community Hospital
483
483 - Baptist Health Deaconess Madisonville Inc
483
483 - MedMira Laboratories Inc.
483
483 - Fenwal International, Inc.
483
483 - Integra LifeSciences Sales LLC
483
483 - OneBlood, Inc.
483
483 - American Red Cross Blood Services Tennessee Valley Region
483
483 - BioIntegrate Inc
483
483 - MiMedx Group, Inc.
483
Showing 1-20 of 31 records
Related People (5)
Related Office
Person Information
Name
Cody D. Rickman
Role
Regulatory Personnel
ID: 54deec25-dc65-4402-991a-ad5589bad78b
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.